BR0009838A - Dissulfetos cìclicos de pirrolidincarbonilamino - Google Patents

Dissulfetos cìclicos de pirrolidincarbonilamino

Info

Publication number
BR0009838A
BR0009838A BR0009838-8A BR0009838A BR0009838A BR 0009838 A BR0009838 A BR 0009838A BR 0009838 A BR0009838 A BR 0009838A BR 0009838 A BR0009838 A BR 0009838A
Authority
BR
Brazil
Prior art keywords
compounds
cyclic
pyrrolidinecarbonylamino
disulfides
binding
Prior art date
Application number
BR0009838-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Li Chen
Nader Fotouhi
David Young Jackson
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0009838A publication Critical patent/BR0009838A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR0009838-8A 1999-04-20 2000-04-17 Dissulfetos cìclicos de pirrolidincarbonilamino BR0009838A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13021599P 1999-04-20 1999-04-20
PCT/EP2000/003459 WO2000063234A2 (en) 1999-04-20 2000-04-17 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists

Publications (1)

Publication Number Publication Date
BR0009838A true BR0009838A (pt) 2002-01-08

Family

ID=22443611

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009838-8A BR0009838A (pt) 1999-04-20 2000-04-17 Dissulfetos cìclicos de pirrolidincarbonilamino

Country Status (15)

Country Link
US (1) US6265572B1 (cg-RX-API-DMAC7.html)
EP (1) EP1171452B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002542256A (cg-RX-API-DMAC7.html)
KR (1) KR100636481B1 (cg-RX-API-DMAC7.html)
CN (1) CN1167710C (cg-RX-API-DMAC7.html)
AR (1) AR023546A1 (cg-RX-API-DMAC7.html)
AT (1) ATE337331T1 (cg-RX-API-DMAC7.html)
AU (1) AU769294B2 (cg-RX-API-DMAC7.html)
BR (1) BR0009838A (cg-RX-API-DMAC7.html)
CA (1) CA2370259A1 (cg-RX-API-DMAC7.html)
DE (1) DE60030266T2 (cg-RX-API-DMAC7.html)
ES (1) ES2269141T3 (cg-RX-API-DMAC7.html)
TR (1) TR200103004T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063234A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200108018B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US20090043126A1 (en) * 2005-02-28 2009-02-12 Jordi Bosch I Llado Process and Methods for the Preparation of Gabapentin and Its Intermediates
AU2008219007A1 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
WO2013057096A1 (en) 2011-10-17 2013-04-25 Westfaelische Wilhelms-Universitaet Muenster Assessment of pml risk and methods based thereon
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
WO2020092401A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
ES2987796T3 (es) 2018-10-30 2024-11-18 Gilead Sciences Inc Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
DK3873884T3 (da) 2018-10-30 2025-02-17 Gilead Sciences Inc 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
AU2020329207B2 (en) 2019-08-14 2024-02-29 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds

Also Published As

Publication number Publication date
DE60030266D1 (de) 2006-10-05
EP1171452B1 (en) 2006-08-23
CN1167710C (zh) 2004-09-22
DE60030266T2 (de) 2007-07-19
US6265572B1 (en) 2001-07-24
WO2000063234A2 (en) 2000-10-26
KR20010108517A (ko) 2001-12-07
ES2269141T3 (es) 2007-04-01
KR100636481B1 (ko) 2006-10-18
CN1347419A (zh) 2002-05-01
CA2370259A1 (en) 2000-10-26
TR200103004T2 (tr) 2002-01-21
WO2000063234A3 (en) 2001-01-18
AR023546A1 (es) 2002-09-04
EP1171452A2 (en) 2002-01-16
AU769294B2 (en) 2004-01-22
AU4748200A (en) 2000-11-02
ZA200108018B (en) 2003-03-26
JP2002542256A (ja) 2002-12-10
ATE337331T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
BR9811730A (pt) Derivados de n-aroilfenilalanina
BR9811988A (pt) Derivados de n-alcanoilfenilalanina
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
BR0200782A (pt) Compostos para o tratamento da isquemia
BR9916930A (pt) Compostos heterocìclicos aromáticos comoagentes antiinflamatórios
BR0009167A (pt) Inibidores de enzima impdh
BR0116402A (pt) Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
BR9916678A (pt) Inibidores de trombina
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
ATE353641T1 (de) Benzamide als kaliumkanal-inhibitoren
BR9915518A (pt) Combinações de substâncias ativas fungicidas
TR200002446T2 (tr) Fosfolipaz enzimlerinin inhibitörleri
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR0112786A (pt) Inibidores de inflamação não-esteroidais
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
BR0016195A (pt) 4-pirimidinil-n-acil-l-fenilalaninas
BR0016172A (pt) 4-piridinil-n-acil-l-fenilalaninas
BR0013248A (pt) Inibidores da adesão celular
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
DE69908156D1 (de) Arylsulfonanilid-harnstoffe
BR0001292A (pt) Desfolhante
DE69924352T8 (de) Topische zusammensetzungen zur erhöhung der glutathion produktion
BR9811948A (pt) Secretores de hormÈnio do crescimento
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
DE60045508D1 (de) Dalda-analoge und ihre verwendung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.